What is QuidelOrtho?
QuidelOrtho is a diagnostic testing and clinical lab systems company serving enterprise, public-sector, commercial, consumer, or regulated-market customers.
- Category
- Diagnostic testing and clinical lab systems
- Headquarters
- San Diego, CA
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: QDEL
What is QuidelOrtho?
QuidelOrtho is a diagnostic testing and clinical lab systems company headquartered in San Diego, CA. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
QuidelOrtho is a diagnostic testing and clinical lab systems company headquartered in San Diego, CA. Its public-company profile is most useful for account planning when combined with current filings, investor materials, job posts, product launches, and partner announcements.
For sellers, QuidelOrtho should be mapped as a scaled public-company account rather than an early-stage company. The best timing signals are earnings commentary, capital spending, hiring clusters, product launches, acquisitions, facility investments, and leadership changes.
What does QuidelOrtho offer?
QuidelOrtho's profile centers on Rapid diagnostics, Clinical chemistry, Immunohematology, Molecular testing.
- Rapid diagnostics· Diagnostic testing and clinical lab systems
- Clinical chemistry· Diagnostic testing and clinical lab systems
- Immunohematology· Diagnostic testing and clinical lab systems
- Molecular testing· Diagnostic testing and clinical lab systems
- Lab instruments· Diagnostic testing and clinical lab systems
- Point-of-care tests· Diagnostic testing and clinical lab systems
How does QuidelOrtho make money?
QuidelOrtho makes money through commercial activity tied to diagnostic testing and clinical lab systems.
QuidelOrtho monetizes through the model common to diagnostic testing and clinical lab systems: product sales, recurring services, subscriptions, contracts, distribution, transaction volume, underwriting, regulated utility revenue, or usage depending on the operating unit.
Sales angles should connect to measurable priorities such as margin, growth, uptime, compliance, retention, automation, risk reduction, data quality, customer experience, or field productivity.
Who leads QuidelOrtho?
QuidelOrtho's named executives should be verified on the official leadership or investor-relations page before outreach.
- QuidelOrtho executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- QuidelOrtho finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- QuidelOrtho operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
How do you contact QuidelOrtho's leadership?
QuidelOrtho should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.quidelortho.com- QuidelOrtho investor relationsInvestor relations / corporate contactcontact via https://www.quidelortho.com
- QuidelOrtho media relationsMedia or communications contact routecontact via https://www.quidelortho.com
How is QuidelOrtho funded?
QuidelOrtho's current status is Public company; Nasdaq: QDEL.
QuidelOrtho's capital profile is best understood through its current public-company status: Public company; Nasdaq: QDEL. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capex plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor-relations page and current exchange filings.
How did QuidelOrtho get here?
QuidelOrtho's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingQuidelOrtho is foundedThe company begins building in diagnostic testing and clinical lab systems.
- Scale-upCommercial footprint expandsQuidelOrtho broadens its product, customer, distribution, or geographic reach.
- Public marketsPublic company; Nasdaq: QDELPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are QuidelOrtho's competitors?
QuidelOrtho competes with larger incumbents and focused specialists in diagnostic testing and clinical lab systems.
- Thermo Fisher ScientificLife sciences tools, diagnostics, and services incumbent.
- DanaherLife sciences and diagnostics platform company.
- MedtronicGlobal medical technology competitor.
- PfizerLarge pharmaceutical company with global commercial reach.
- IQVIAHealthcare data and clinical research platform competitor.
QuidelOrtho — frequently asked questions
